Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

NCT06021756 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Arizona

Collaborators